Episurf Medical to Launch Custom Ankle Implants Using Episealer® Technology

In what represents an innovative method to treat osteochondral lesions of the talus in the ankle, Stockholm, Sweden-based Episurf Medical is preparing to launch patient-specific Episealer® ankle implants.

This represents a new direction for the Episealer® technology, which Episurf developed to treat damaged knee cartilage with a patient-specific design based on medical imaging and 3D modeling. (Three Episealer knee devices are approved and commercialized in Europe, presently.)

The company seeks to perform the first ankle procedures in 2Q18.

In 2016, a surgeon implanted one patient in Germany with a custom-made Episurf device to treat an ankle joint lesion. The device was built to the surgeon’s specifications in a complex case for which a patient-specific implant was reported to be the only option. The procedure was deemed successful and the patient reported excellent results at 12-month follow-up.

Present approaches to treat osteochondral talus defects include arthroscopic debridement and bone marrow stimulation, autograft transfer, autogenous cancellous bone graft, ACI, metal resurfacing, etc.

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE